首页> 外文期刊>Journal of interventional oncology >Should Microwave Energy Be Preferred to Radiofrequency Energy for Ablation of Malignant Liver Tumors ?
【24h】

Should Microwave Energy Be Preferred to Radiofrequency Energy for Ablation of Malignant Liver Tumors ?

机译:消融恶性肝肿瘤应该用微波能量代替射频能量吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Microwave ablation (MWA) and radiofrequency ablation (RFA) can destroy unresectable liver cancer, but the efficacy and safety of MWA are unclear. Objective: To compare survival between MWA and RFA performed during a similar time period. Methods: The study population comprised 51 patients undergoing open (88.2%) or laparoscopic (11.8%) MWA or RFA for hepatic malignancy during a 3-year period. Results: Twenty-one patients underwent MWA and 30 patients underwent RFA for 117 lesions, usually colorectal cancer. Most MWA (90%) and RFA (85%) patients underwent concurrent liver resection; 28.6% of MWA and 11.1% of RFA patients had previous liver surgery (p = .15). The mean number of lesions ablated (2.6 vs 2.4), total ablation zone diameter (8.5 vs 7.2 cm), total ablation time (15 vs 17 minutes), and total surgical time (240.0 vs 228.8 minutes) were not significantly different for MWA versus RFA. With a median follow-up of 20.4 months, the median overall survival for MWA versus RFA patients was 18 versus 30 months (p = .50), or 32 versus 30 months for those with colorectal cancer (p = .57). Morbidity and mortality were not significantly different after MWA versus RFA. Conclusions: Although MWA and RFA appear to have equivalent survival and safety, MWA is easier to use.
机译:背景:微波消融(MWA)和射频消融(RFA)可以摧毁无法切除的肝癌,但MWA的疗效和安全性尚不清楚。目的:比较在相同时间段内进行的MWA和RFA的生存率。方法:该研究人群包括51名在3年期间因肝恶性而接受开腹(88.2%)或腹腔镜(11.8%)MWA或RFA治疗的患者。结果:21例患者接受了MWA,30例患者接受了RFA,治疗117个病变,通常是结直肠癌。大部分MWA(90%)和RFA(85%)患者同时进行肝切除。 MWA的28.6%和RFA患者的11.1%曾接受过肝脏手术(p = .15)。与MWA相比,平均消融灶数(2.6 vs 2.4),总消融区直径(8.5 vs 7.2 cm),总消融时间(15 vs 17分钟)和总手术时间(240.0 vs 228.8分钟)没有显着差异。 RFA。中位随访时间为20.4个月,MWA与RFA患者的平均总生存期分别为18个月与30个月(p = 0.50),或结直肠癌患者的32个月与30个月(p = 0.57)。 MWA与RFA后的发病率和死亡率无显着差异。结论:尽管MWA和RFA似乎具有相同的生存和安全性,但MWA更易于使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号